Comparing 3 vs 7 day insulin pump wear in teens with type 1 diabetes
Part of Hormones & metabolism, Immune system & allergy clinical trials.
This study tests if wearing an insulin pump set for 7 days is as safe and effective as changing it every 3 days. It is for children and teens with type 1 diabetes who already use the Medtronic 780G system.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have type 1 diabetes (T1D)
- You have had diabetes for more than 6 months
- You are between 7 and 18 years old
- You are already using or plan to use the Medtronic 780G pump and sensor system
- Your total daily insulin dose is more than 8 units per day
- You can understand and read Danish
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests if a simpler way of calculating meal insulin works as well as counting carbohydrates for teens using hybrid closed loop (automated insulin) systems. If you're a teen with type 1 diabetes and use an automated pump, this trial could help find an easier mealtime routine.
This study tests a new automated insulin delivery system to help people with type 1 diabetes better manage their blood sugar. It aims to see if the system improves glucose control safely.
This study tests how well the Tandem Mobi insulin pump and Dexcom continuous glucose monitor work for young competitive athletes with type 1 diabetes. If you join, you'll use this system during your regular training and competition to see how safe and easy it is.
This study tests a system that measures blood sugar and automatically adjusts insulin delivery. It is for adults with type 1 diabetes who use insulin injections or a pump.
This study tests a smart insulin pump system that adjusts automatically during exercise. It aims to make managing blood sugar easier and safer.
This study tests a semi-automated insulin pump system in very young children (ages 2–6) with type 1 diabetes. It aims to see if the device improves quality of life and blood sugar control.
Hear when a new Type 1 diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.